ADHD in children, adolescents and adults is increasingly discussed in the virtual arena and at major International and European congresses focusing on mental health and psychiatry

Meeting of Minds is a scientific and educational meeting initiated, organised and funded by Takeda, with the objective of providing a forum for scientists and clinicians to discuss the latest scientific evidence and share best practice in the management of attention-deficit hyperactivity disorder (ADHD), or hyperkinetic disorder (HKD). Read more to find out what happened at Meeting of Minds XVI (14–15 November 2024).

There are a number of International and European congresses, such as the European College of Neuropsychopharmacology (ECNP) Congress, the European Congress of Psychiatry, the European Society for Child and Adolescent Psychiatry (ESCAP) International Congress, the World Congress on ADHD and the World Psychiatric Association (WPA) International Congress. To find out dates and locations visit the congress calendar.